Anticoagulation for mechanical heart valves during pregnancy: A case report and a literature review

Medicine (Baltimore). 2022 Dec 30;101(52):e32550. doi: 10.1097/MD.0000000000032550.

Abstract

Rationale: Most previous treatment guidelines for pregnant women with mechanical heart valves recommend that low molecular weight heparin (LMWH) should be applied once every 12 hours and only as required to reach peak anti-Xa levels of approximately 1.0 to 1.2 IU/mL, but it is commonly associated with subtherapeutic trough levels, consequently with an inadequate level of anticoagulation. Our case report here together with a literature review suggests that dose-adjusted (Target trough anti-Xa levels of 0.6 to 0.7 IU/mL and with peak anti-Xa levels of around 1.0 to 1.2 IU/mL or < 1.5 IU/mL) LMWH should be given thrice daily throughout pregnancy. In addition, the findings of this rare case indicate that a combination of LMWH and warfarin is effective in the treatment of small thromboses in pregnancy.

Patient concerns: In the 1st trimester of pregnancy, a 28-year old pregnant female with a mechanical valve had a significant increase in the aortic valve flow rate and suspected mechanical valve thrombosis.

Diagnoses: The peak velocity of the pregnant female aortic mechanical valve increased, and mechanical valve thrombosis was suspected.

Interventions: We adjusted the enoxaparin sodium dose every 12 hours to 1 injection every 8 hours, with a total daily dose of 160 mL. Based on the original application of LMWH, warfarin (3 mg/day) was recommended.

Outcomes: The pregnant woman delivered a live baby by cesarean section, and the peak flow velocity of the mechanical valve in the aortic position was reduced to nearly equivalent to the patient's pre-pregnancy status. The mother and the baby were in good health at the time of discharge.

Lessons: LMWH is administered twice daily, and anti-Xa trough levels are mostly in a subtherapeutic state, which may lead to insufficient anticoagulation and thrombosis. Dose-adjusted LMWH thrice daily throughout pregnancy is the recommended treatment for pregnant women with mechanical heart valves. The combination of LMWH and warfarin exhibited good efficacy for the treatment of small thromboses.

Publication types

  • Review
  • Case Reports

MeSH terms

  • Adult
  • Anticoagulants / therapeutic use
  • Aortic Valve
  • Cesarean Section
  • Female
  • Heart Valve Prosthesis* / adverse effects
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Pregnancy
  • Pregnancy Complications, Cardiovascular* / drug therapy
  • Thrombosis* / drug therapy
  • Thrombosis* / etiology
  • Warfarin / therapeutic use

Substances

  • Heparin, Low-Molecular-Weight
  • Anticoagulants
  • Warfarin